Facebook Pixel

Phyllis Greenberger, M.S.W.

The first president and CEO of the Society for Women’s Health Research, a Washington, D.C., based advocacy organization formed in 1990 to improve the health of women through research.

The Society was the driving force behind the 2001 Institute of Medicine report “Exploring the Biological Contributions to Human Health: Does Sex Matter?” that called on researchers to understand the implications of basic biological sex differences for the betterment of human health.

The Medical Herald selected Greenberger as one of the twenty most influential women in medicine today. She has been quoted in numerous publications including: The New York Times, The Washington Post, The Washington Times, The Wall Street Journal, and US News and World Report. She is frequently called upon to speak on topics such as the importance of the inclusion and retention of women in clinical trials and the importance of sex-based biology and gender-based medicine.

Greenberger frequently testifies before Congress advocating for additional research and funding for women’s health.
She serves on many boards of directors, advisory and editorial boards, and was a member of the Research Committee of the Presidential HIV/AIDS Advisory Council (PACHA) and the National Institutes of Health’s National Advisory Environmental Health Sciences Council (NAEHS). Currently, she serves on the Advisory Board for the Association of Black Cardiologists’ Center for Women’s Health, the Board of Advisors for the Iris Alliance Fund, and as the consumer representative to the Medicare Coverage Advisory Committee (MCAC) for the Centers for Medicare and Medicaid Services (CMS) and has been a consistent advocate for coverage for new technologies.